- Home
- GEG vs ASRT Comparison
GEG vs ASRT Comparison
Compare GEG & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- ASRT
- Stock Information
- Founded
- GEG 1994
- ASRT 1995
- Country
- GEG United States
- ASRT United States
- Employees
- GEG N/A
- ASRT N/A
- Industry
- GEG Computer Software: Prepackaged Software
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- GEG Technology
- ASRT Health Care
- Exchange
- GEG Nasdaq
- ASRT Nasdaq
- Market Cap
- GEG 72.4M
- ASRT 79.1M
- IPO Year
- GEG N/A
- ASRT 1997
- Fundamental
- Price
- GEG $2.99
- ASRT $0.80
- Analyst Decision
- GEG
- ASRT Strong Buy
- Analyst Count
- GEG 0
- ASRT 1
- Target Price
- GEG N/A
- ASRT $3.00
- AVG Volume (30 Days)
- GEG 894.7K
- ASRT 180.3K
- Earning Date
- GEG 11-10-2025
- ASRT 11-10-2025
- Dividend Yield
- GEG N/A
- ASRT N/A
- EPS Growth
- GEG N/A
- ASRT N/A
- EPS
- GEG 0.38
- ASRT N/A
- Revenue
- GEG $16,315,999.00
- ASRT $117,099,000.00
- Revenue This Year
- GEG N/A
- ASRT N/A
- Revenue Next Year
- GEG N/A
- ASRT $5.84
- P/E Ratio
- GEG $7.47
- ASRT N/A
- Revenue Growth
- GEG N/A
- ASRT N/A
- 52 Week Low
- GEG $1.70
- ASRT $0.51
- 52 Week High
- GEG $3.51
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- GEG 64.49
- ASRT 54.44
- Support Level
- GEG $2.58
- ASRT $0.78
- Resistance Level
- GEG $2.99
- ASRT $0.83
- Average True Range (ATR)
- GEG 0.25
- ASRT 0.03
- MACD
- GEG 0.01
- ASRT -0.00
- Stochastic Oscillator
- GEG 49.80
- ASRT 37.18
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.